Ivan Mascanfroni

Company: Seismic Therapeutic

Job title: Senior Director - Immunology

Seminars:

Engineering Non-Human Proteins with Machine Learning to Reduce Immunogenicity 3:00 pm

Demonstrate how AI-driven platforms can redesign bacterial-derived proteins to reduce immunogenicity and enhance therapeutic potential Validating assays and strategies to reliably evaluate immunogenicity risks during drug development Removing T-cell and B-cell epitopes to tackle stability and manufacturabilityRead more

day: Conference Day Two